Latest filing published 26 Aug 2026 for Ocular Therapeutix, INC, €18k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sanjay Nayak in Ocular Therapeutix, Inc. Between 22 February 2024 and 24 August 2026, the trades on record add up to 13 filings.
No open-market purchase appears, only 10 sales worth €215k. The rest of the record consists of 3 share grants. So far in 2026, the count stands at no purchases and 3 sales.
The latest filing, published on 26 August 2026, reports an open-market sale of €18k in Ocular Therapeutix, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations